Nigeria’s Ban On Codeine Cough Syrups Could Spur Black Market If Demand Not Addressed

Washington Post: Nigeria bans codeine cough syrup to stop an addiction epidemic. But something worse could take its place
“…Nigerian lawmakers estimate that the residents of just two states in the country’s north consume more than three million bottles of [codeine cough syrup] each day. … Now the country’s health ministry has banned the import and production of the painkilling medicine-turned-street-drug. … But the ban might not do much to end Nigeria’s pharmaceutical-addiction problem. ‘The cough syrup challenge is just a symptom of a faulty system,’ said Adeolu Ogunrombi, a project coordinator at Youth RISE Nigeria, an organization that researches drug-policy reform. … ‘There is still a huge demand, and a criminal market is going to spring up to meet the needs of the users who are in need of the substances,’ he said…” (O’Grady, 5/4).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.